Cardinal Capital Management Jazz Pharmaceuticals PLC Transaction History

Cardinal Capital Management

$631 Million
Q3 2024

A detailed history of Cardinal Capital Management transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Cardinal Capital Management holds 12,499 shares of JAZZ stock, worth $1.57 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

12,499

Previous 12,068 3.57%

Holding current value

$1.57 Million

Previous $1.29 Million 8.15%

% of portfolio

0.22%

Previous 0.22%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$100.57 - $116.37 $43,345 - $50,155	431 Added 3.57%	12,499 $1.39 Million
Q2 2024 Jul 12, 2024	BUY	$103.94 - $118.98 $23,594 - $27,008	227 Added 1.92%	12,068 $1.29 Million
Q1 2024 Jul 12, 2024	BUY	$115.19 - $132.77 $185,571 - $213,892	1,611 Added 15.75%	11,841 $1.43 Million
Q1 2024 Apr 15, 2024	BUY	$115.19 - $132.77 $185,571 - $213,892	1,611 Added 15.75%	11,841 $1.43 Million
Q4 2023 Jul 12, 2024	BUY	$114.26 - $136.0 $28,107 - $33,456	246 Added 2.46%	10,230 $1.26 Million
Q4 2023 Jan 26, 2024	BUY	$114.26 - $136.0 $28,107 - $33,456	246 Added 2.46%	10,230 $1.26 Million
Q3 2023 Jul 12, 2024	BUY	$122.0 - $145.31 $38,430 - $45,772	315 Added 3.26%	9,984 $1.29 Million
Q3 2023 Oct 16, 2023	BUY	$122.0 - $145.31 $38,430 - $45,772	315 Added 3.26%	9,984 $1.29 Million
Q2 2023 Jul 12, 2024	SELL	$122.5 - $147.16 $266,070 - $319,631	-2,172 Reduced 18.34%	9,669 $1.2 Million
Q2 2023 Jul 12, 2023	BUY	$122.5 - $147.16 $5,512 - $6,622	45 Added 0.47%	9,669 $1.2 Million
Q1 2023 Apr 18, 2023	SELL	$133.98 - $160.47 $8,842 - $10,591	-66 Reduced 0.68%	9,624 $1.41 Million
Q4 2022 Jan 20, 2023	BUY	$129.72 - $159.85 $4,410 - $5,434	34 Added 0.35%	9,690 $0
Q3 2022 Oct 21, 2022	SELL	$126.59 - $161.18 $12,279 - $15,634	-97 Reduced 0.99%	9,656 $1.29 Million
Q2 2022 Aug 04, 2022	BUY	$141.59 - $168.66 $30,725 - $36,599	217 Added 2.28%	9,753 $1.52 Million
Q1 2022 Apr 21, 2022	BUY	$129.64 - $160.7 $52,374 - $64,922	404 Added 4.42%	9,536 $1.48 Million
Q4 2021 Jan 18, 2022	BUY	$119.87 - $145.67 $18,699 - $22,724	156 Added 1.74%	9,132 $1.16 Million
Q3 2021 Oct 21, 2021	BUY	$128.64 - $184.79 $32,031 - $46,012	249 Added 2.85%	8,976 $1.17 Million
Q2 2021 Jul 14, 2021	BUY	$160.2 - $186.42 $437,506 - $509,113	2,731 Added 45.55%	8,727 $1.55 Million
Q1 2021 Apr 19, 2021	BUY	$150.19 - $173.5 $17,271 - $19,952	115 Added 1.96%	5,996 $986,000
Q4 2020 Feb 01, 2021	BUY	$140.71 - $165.05 $52,766 - $61,893	375 Added 6.81%	5,881 $971,000
Q3 2020 Oct 16, 2020	BUY	$105.46 - $144.13 $111,893 - $152,921	1,061 Added 23.87%	5,506 $785,000
Q2 2020 Jul 16, 2020	BUY	$95.68 - $121.88 $191 - $243	2 Added 0.05%	4,445 $490,000
Q1 2020 Apr 20, 2020	BUY	$87.74 - $152.74 $389,828 - $678,623	4,443 New	4,443 $443,000

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.89B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardinal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Cardinal Capital Management with notifications on news.

Account

Cardinal Capital Management Jazz Pharmaceuticals PLC Transaction History